A fibroblast-specific gene signature as a therapeutic target for glioblastoma developed based on the characteristics of tumor microenvironment

Abstract Background This study identified fibroblast-specific genes to develop a RiskScore model to improve prognostic accuracy and guide personalized treatment in glioblastoma (GBM). Methods We analyzed fibroblast-specific signatures in the GSE273274 cohort using “Seurat” R package for scRNA-seq da...

Descrición completa

Detalles Bibliográficos

Principais autores:	Nan Liu, Mingyue Zhao, Yeting Cui, Jiaxuan Zhao, Yanyang Tu, Tongcun Zhang, Xiaofei Hu
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2025-11-01
Series:	European Journal of Medical Research
Assuntos:	Glioblastoma scRNA-seq analysis Fibroblasts signature Prognosis Drug sensitivity
Acceso en liña:	https://doi.org/10.1186/s40001-025-03528-w
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!